These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6096979

  • 1. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN, Valueva GV, Luchitskiĭ EV.
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV, Luchitskiĭ EV, Iakovlev AA.
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [Abstract] [Full Text] [Related]

  • 5. [Neurotensin in Itsenko-Cushing disease].
    Slavnov VN, Luchitskiĭ EV, Iakovlev AA, Komissarenko IV, Valueva GV.
    Probl Endokrinol (Mosk); 1984; 30(4):35-40. PubMed ID: 6382246
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Function of the hypophysis in patients with Itsenko-Cushing disease treated with peritol and chloditan].
    Slavnov VN, Valueva GV, Luchitskiĭ EV.
    Klin Med (Mosk); 1983 Oct; 61(10):27-31. PubMed ID: 6417399
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV, Cheban AK, Rybakov SI, Pomerantsev YuV, Slavnov VI, Luchitskii EV.
    Neurosci Behav Physiol; 1982 Oct; 12(6):494-6. PubMed ID: 6314174
    [No Abstract] [Full Text] [Related]

  • 10. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin].
    Slavnov VN, Luchitskiĭ EV.
    Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280
    [Abstract] [Full Text] [Related]

  • 11. [ACTH, beta-endorphin and lipotropins: physiopathological studies in man (author's transl)].
    Kuhn JM, Luton JP, Bricaire H.
    Ann Med Interne (Paris); 1982 Mar; 133(3):148-51. PubMed ID: 6285791
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on drug therapy of Cushing's syndrome].
    Winkelmann W, Fricke U, Hackenberg K, Heesen D, Hoff HG, Hummerich W, Liesen H.
    Verh Dtsch Ges Inn Med; 1982 Mar; 83():1337-40. PubMed ID: 347777
    [No Abstract] [Full Text] [Related]

  • 20. Human plasma immunoreactive lipotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease.
    Krieger DT, Liotta AS, Suda T, Goodgold A, Condon E.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):566-71. PubMed ID: 219000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.